Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 8.70M | £ 9.20M | £ 6.90M | £ 6.90M | £ 4.60M |
Total Assets | £ 33.90M | £ 36.80M | £ 28.20M | £ 35.60M | £ 46.10M |
Total Debt | £ 20.30M | £ 20.20M | £ 20.20M | £ 20.40M | £ 42.40M |
Net Debt | £ 11.60M | £ 11.00M | £ 13.30M | £ 13.50M | £ 37.80M |
Total Liabilities | £ 32.70M | £ 35.30M | £ 65.40M | £ 78.60M | £ 109.00M |
Stockholders Equity | £ 1.20M | £ 1.50M | £ -37.20M | £ -43.00M | £ -62.90M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |